Book contents
- Fetal Therapy
- Fetal Therapy
- Copyright page
- Dedication
- Contents
- Contributors
- Foreword
- Section 1: General Principles
- Chapter 1 The Rationale for Fetal Therapy
- Chapter 2 A Fetal Origin of Adult Disease
- Chapter 3 Human Embryology: Molecular Mechanisms of Embryonic Disease
- Chapter 4 Human Genetics and Fetal Disease: Assessment of the Fetal Genome
- Chapter 5 Interventions in Pregnancy to Reduce Risk of Stillbirth
- Chapter 6 Fetal Therapy Choices: Uncertain and Emotional Decisions and the Doctor’s Role in Parental Decision-Making
- Chapter 7 The Ethics of Consent for Fetal Therapy
- Chapter 8 Open Fetal Surgery: Is There Still a Role?
- Chapter 9 The Artificial Womb
- Section 2: Fetal Disease: Pathogenesis and Treatment
- Section III: The Future
- Index
- References
Chapter 9 - The Artificial Womb
from Section 1: - General Principles
Published online by Cambridge University Press: 21 October 2019
Book contents
- Fetal Therapy
- Fetal Therapy
- Copyright page
- Dedication
- Contents
- Contributors
- Foreword
- Section 1: General Principles
- Chapter 1 The Rationale for Fetal Therapy
- Chapter 2 A Fetal Origin of Adult Disease
- Chapter 3 Human Embryology: Molecular Mechanisms of Embryonic Disease
- Chapter 4 Human Genetics and Fetal Disease: Assessment of the Fetal Genome
- Chapter 5 Interventions in Pregnancy to Reduce Risk of Stillbirth
- Chapter 6 Fetal Therapy Choices: Uncertain and Emotional Decisions and the Doctor’s Role in Parental Decision-Making
- Chapter 7 The Ethics of Consent for Fetal Therapy
- Chapter 8 Open Fetal Surgery: Is There Still a Role?
- Chapter 9 The Artificial Womb
- Section 2: Fetal Disease: Pathogenesis and Treatment
- Section III: The Future
- Index
- References
Summary
Despite advances in neonatal intensive care, prematurity remains an unsolved clinical challenge and a leading cause of infant morbidity and mortality [1]. Approximately 6% of all live births in the USA are considered extremely preterm (delivery at less than 28 weeks’ gestation), and the incidence of prematurity has slowly risen over the past decade [2]. Prematurity is thought to account for one-third of infant mortality [3], one-half of cerebral palsy, and 80% of survivors born at 22–28 weeks’ gestation will suffer at least one major co-morbidity [4].
- Type
- Chapter
- Information
- Fetal TherapyScientific Basis and Critical Appraisal of Clinical Benefits, pp. 83 - 90Publisher: Cambridge University PressPrint publication year: 2020
References
March of Dimes, Partnership for Maternal, Newborn, and Child Health, Save the Children, WHO. Born too soon: the global action report on preterm birth. Geneva: World Health Organization, 2012.Google Scholar
Glass, HC, Costarino, AT, Stayer, SA, Brett, CM, Cladis, F, Davis, PJ. Outcomes for extremely premature infants. Anesth Analg. 2015; 120: 1337–51.Google Scholar
Callaghan, WM, MacDorman, MF, Rasmussen, SA, Qin, C, Lackritz, EM. The contribution of preterm birth to infant mortality rates in the United States. Pediatrics. 2006; 118: 1566–73.Google Scholar
Anderson, JG, Baer, RJ, Partridge, JC, Kuppermann, M, Franck, LS, Rand, L, Jelliffe-Pawlowski, LL, Rogers, EE. Survival and major morbidity of extremely preterm infants: a population-based study. Pediatrics. 2016; 138: e20154434.Google Scholar
Coalson, JJ. Pathology of new bronchopulmonary dysplasia. Semin Neonatol. 2003; 8: 73–81.Google Scholar
Maynes, EA, Callaghan, JC. A new method of oxygenation: a study of its use in respiratory support and the artificial placenta. Ann Surg. 1963; 158: 537–42.Google Scholar
Zapol, WM, Kolobow, T, Pierce, JG, Bowman, RL. Artificial placenta: two days of total extrauterine support of the isolated premature lamb fetus. Science. 1969; 166: 617–18.Google Scholar
Kuwabara, Y, Okai, T, Imanishi, Y, Muronosono, E, Kozuma, S, Takeda, S, Baba, K, Mizuno, M. Development of extrauterine fetal incubation system using extracorporeal membrane oxygenator. Artif Organs 1986; 11; 224–77.Google Scholar
Kuwabara, Y, Okai, T, Kozuma, S, Unno, N, Akiba, K, Shinozuka, N, Maeda, T, Mizuno, M. Artificial placenta: long-term extrauterine incubation of isolated goat fetuses. Artif Organs. 1989; 13: 527–31.CrossRefGoogle ScholarPubMed
Unno, N, Kuwabara, Y, Okai, T, Kido, K, Nakayama, H, Narumiya, Y, Kozuma, S, Taketani, Y, Tamura, M. Development of an artificial placenta: survival of isolated goat fetuses for up to three weeks with umbilical arteriovenous extracorporeal oxygenation. Artif Organs. 1993; 17: 996–1003.CrossRefGoogle Scholar
Unno, N, Baba, K, Kozuma, S, Nishina, H, Okai, T, Kuwabara, Y, Taketani, Y. An evaluation of the system to control blood flow in maintaining goat fetuses on arterio-venous extracorporeal membrane oxygenation: a novel approach to the development of an artificial placenta. Artif Organs. 1997; 21: 1239–46.Google Scholar
Yasufuku, M, Hisano, K, Sakata, M, Okada, M. Arterio-venous extracorporeal membrane oxygenation of fetal goat incubated in artificial amniotic fluid (artificial placenta): influence on lung growth and maturation. J Pediatr Surg. 1998; 33: 442–8.Google Scholar
Pak, SC, Song, CH, So, GY, Jang, CH, Lee, KH, Kim, JY. Extrauterine incubation of fetal goats applying the extracorporeal membrane oxygenation via umbilical artery and vein. J Korean Med Sci. 2002; 17: 663–8.CrossRefGoogle ScholarPubMed
Awad, JA, Cloutier, R, Fournier, L, Major, D, Martin, L, Masson, M, Guidoin, R. Pumpless respiratory assistance using a membrane oxygenator as an artificial placenta: a preliminary study in newborn and preterm lambs. J Invest Surg. 1995; 8: 21–30.CrossRefGoogle ScholarPubMed
Reoma, JL, Rojas, A, Kim, AC, Khouri, JS, Boothman, E, Brown, K, et al. Development of an artificial placenta I: pumpless arterio-venous extracorporeal life support in a neonatal sheep model. J Pediatr Surg. 2009; 44: 53–9.Google Scholar
Mirua, Y, Matsuda, T, Funakubo, A, Watanabe, S, Kitanishi, R, Saito, M, Hanita, T. Novel modification of an artificial placenta: pumpless arteriovenous extracorporeal life support in a premature lamb model. Pediatr Res. 2002; 72: 490–94.Google Scholar
Schoberer, M, Arens, J, Erben, A, Ophelders, D, Jellema, RK, Kramer, BW, et al. Miniaturization: the clue to clinical application of the artificial placenta. Artif Organs. 2014; 38: 208–14.Google Scholar
Gray, BW, El-Sabbagh, A, Zakem, SJ, Kock, KL, Rojas-Pena, A, Owens, GE, et al. Development of an artificial placenta V: 70h veno-venous extracorporeal life support after ventilatory failure in premature lambs. J Pediatr Surg. 2013; 48: 145–53.Google Scholar
Bryner, B, Gray, B, Perkins, E, Davis, R, Hoffman, H, Barks, J, et al. An extracorporeal placenta supports extremely premature lambs for one week. J Pediatr Surg. 2015; 50: 44–49.Google Scholar
Partridge, EA, Davey, MG, Hornick, MA, McGovern, PE, Majaddam, AY, Vrecenak, JD, et al. An extra-uterine system to physiologically support the extreme preterm lamb. Nat Comm. 2017; 8: 15112.Google Scholar
Beall, MH, van den Wijngaard, JPHM, van Gemert, MJ, Ross, MG. Amniotic fluid water dynamics. Placenta. 2007; 28: 816–23.CrossRefGoogle ScholarPubMed
Hornick, MA, Davey, MG, Partridge, EA, Mejaddam, AY, McGovern, PE, Olive, AM, et al. Umbilical cannulation optimizes circuit flows in premature lambs supported by the EXTra-uterine Environment for Neonatal Development (EXTEND). J Physiol. 2018; 596: 1575–85.Google Scholar
Stockmann, C, Fandrey, J. Hypoxia-induced erythropoietin production: a paradigm for oxygen-regulated gene expression. Clin Exp Pharmacol Physiol. 2006; 33: 968–79.CrossRefGoogle ScholarPubMed
Creasy, RK, Drost, M, Green, MV, Morris, JA. Determination of fetal, placental and neonatal blood volumes in the sheep. Circ Res. 1970; 27: 487–94.Google Scholar
Faber, JJ, Green, TJ. Foetal placental blood flow in the lamb. J Physiol. 1972; 223: 375–93.Google Scholar
Hanif, F, Drennan, K, Mari, G. Variables that affect the middle cerebral artery peak systolic velocity in fetuses with anemia and intrauterine growth restriction. Am J Perinatol. 2007; 24: 501–5.Google Scholar
Papademetriou, M, Tachtsidis, I, Elliott, MJ, Hoskote, A, Elwell, CE. Wavelet cross-correlation to investigate regional variations in cerebral oxygenation in infants supported on extracorporeal membrane oxygenation. Adv Exp Med Biol .2013; 765; 203–9.Google Scholar
Short, BL, Walker, LK, Bender, KS, Travstman, RJ. Impairment of cerebral autoregulation during extracorporeal membrane oxygenation in newborn lambs. Pediatr Res. 1993; 33: 289–94.CrossRefGoogle ScholarPubMed
Stolar, CJ, Reyes, C. Extracorporeal membrane oxygenation causes significant changes in intracranial pressure and carotid artery blood flow in newborn lambs. J Pediatr Surg. 1988; 23: 1163–8.Google Scholar
Walker, LK, Short, BL, Travstman, RJ. Impairment of cerebral autoregulation during venovenous extracorporeal membrane oxygenation in the newborn lamb. Crit Care Med. 1996; 24: 2001–6.Google Scholar
Iisselstiin, H, van Heist, AF. Long-term outcome of children treated with neonatal extracorporeal membrane oxygenation: increasing problems with increasing age. Semin Perinatol. 2014; 38: 114–121.Google Scholar
Kumar, P, Bedard, MP, Shankaran, S, Delaney-Black, V. Post extracorporeal membrane oxygenation single photon emission computed tomography (SPECT) as a predictor of neurodevelopmental outcome. Pediatrics. 1994; 93: 951–55.Google Scholar
Danzer, E, Hoffman, C, D’Agostino, JA, Connelly, JT, Wagar, LN, Gerdes, M, et al. Short-term neurodevelopmental outcome in congenital diaphragmatic hernia: the impact of extracorporeal membrane oxygenation and timing of repair. Pediatr Crit Care Med. 2018; 19: 64–74.Google Scholar
Miura, Y, Saito, M, Usuda, H, Woodward, E, Rittenschober-Bohm, J, Kannan, PS, et al. Ex-Vivo uterine environment (EVE) therapy induced limited fetal inflammation in a premature lamb model. PLOS One. 2015; 10: 1–17.Google Scholar
Usuda, H, Watanabe, S, Miura, Y, Saito, M, Musk, GC, Rittenschober-Bohm, J, et al. Successful maintenance of key physiological parameters in preterm lambs treated with ex vivo uterine environment therapy for a period of 1 week. Am J Obstet Gynecol. 2017; 217: 457. e1–13.Google Scholar
- 2
- Cited by